Identifying breast cancer recurrences using routinely collected data

  • Research type

    Research Study

  • Full title

    Study to investigate the accuracy with which breast cancer recurrence can be identified in women registered with invasive breast cancer using routinely collected data compared with recurrence information collected by the AZURE trial

  • IRAS ID

    232895

  • Contact name

    Gurdeep S. Mannu

  • Contact email

    gurdeep.mannu@ndph.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    There is no reliable population level information on breast cancer recurrence in the UK. To address this, researchers at the University of Oxford have been collaborating with Public Health England to identify recurrences in women registered with breast cancer using a number of routinely collected data sources. As part of this study, an algorithm has been developed to identify which women have had a recurrence of their breast cancer and, for those who did, the date of the recurrence. This algorithm has had promising results when validated internally against recurrence information collected by the former West Midlands Cancer Intelligence Unit. However, it has not yet been validated nationally against an external and independent dataset. The aim of this project is to undertake this external validation using data from a UK-based randomized controlled trial. If can be shown that the algorithm produces valid results, then it will be possible for the first time to have nationwide long-term recurrence data for women with breast cancer.

  • REC name

    West Midlands - Solihull Research Ethics Committee

  • REC reference

    17/WM/0347

  • Date of REC Opinion

    15 Sep 2017

  • REC opinion

    Further Information Favourable Opinion